X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1406) 1406
Book Review (381) 381
Publication (257) 257
Book Chapter (11) 11
Book / eBook (8) 8
Conference Proceeding (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1286) 1286
animals (948) 948
humans (688) 688
male (509) 509
atp (376) 376
rats (349) 349
neurosciences (342) 342
adenosine triphosphate - pharmacology (261) 261
mice (253) 253
female (247) 247
receptors, purinergic p2 - metabolism (240) 240
pharmacology & pharmacy (224) 224
adenosine triphosphate - metabolism (203) 203
adenosine (191) 191
physiology (189) 189
purinergic p2 receptor antagonists (174) 174
rats, sprague-dawley (174) 174
extracellular atp (165) 165
adenosine triphosphate - analogs & derivatives (161) 161
dose-response relationship, drug (156) 156
purinergic receptors (156) 156
cell biology (155) 155
receptors, purinergic p2 - physiology (148) 148
signal transduction (141) 141
receptors (135) 135
clopidogrel (133) 133
physiological aspects (133) 133
ticlopidine - analogs & derivatives (133) 133
p2x receptors (130) 130
inflammation (128) 128
calcium - metabolism (124) 124
activation (123) 123
cells, cultured (122) 122
biomedicine (121) 121
p2y (120) 120
middle aged (116) 116
adenosine triphosphate (105) 105
rodents (105) 105
platelet aggregation - drug effects (103) 103
neurons (102) 102
nucleotides (102) 102
biochemistry & molecular biology (101) 101
platelet aggregation inhibitors - pharmacology (101) 101
hematology (100) 100
blood platelets - drug effects (98) 98
peripheral vascular disease (98) 98
disease models, animal (97) 97
platelet aggregation inhibitors - therapeutic use (96) 96
purinergic p2 receptor agonists (95) 95
purinergic p2y receptor antagonists - pharmacology (95) 95
rats, wistar (94) 94
research (94) 94
adenosine diphosphate - pharmacology (93) 93
analysis (93) 93
p2x receptor (93) 93
mice, inbred c57bl (91) 91
signal transduction - physiology (91) 91
pharmacology/toxicology (89) 89
aged (87) 87
expression (86) 86
human physiology (86) 86
article (85) 85
receptors, purinergic - metabolism (85) 85
inhibition (84) 84
p2y receptor (84) 84
receptors, purinergic p2 - genetics (84) 84
in vitro techniques (83) 83
neuropathic pain (81) 81
receptor (81) 81
p2y receptors (80) 80
adult (79) 79
cardiac & cardiovascular systems (77) 77
release (77) 77
time factors (77) 77
cells (75) 75
p2 receptors (75) 75
cancer research (74) 74
p2x (74) 74
platelets (73) 73
pyridoxal phosphate - analogs & derivatives (73) 73
sensory neurons (73) 73
pain (72) 72
signal transduction - drug effects (71) 71
aspirin (70) 70
neurons - metabolism (70) 70
adenosine - analogs & derivatives (69) 69
neurology (68) 68
percutaneous coronary intervention (68) 68
prasugrel (68) 68
receptors, purinergic p2 - drug effects (68) 68
pyridoxal phosphate - pharmacology (66) 66
calcium (65) 65
treatment outcome (65) 65
biomedicine general (64) 64
ticlopidine - therapeutic use (64) 64
blood platelets - metabolism (63) 63
rat (63) 63
mice, knockout (62) 62
receptors, purinergic p2x7 - metabolism (62) 62
acute coronary syndromes (61) 61
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Immunobiology, ISSN 0171-2985, 2010, Volume 216, Issue 1, pp. 1 - 11
Abstract Phagocytosis plays an important role in controlling inflammation and antigen cross-presentation through the uptake of apoptotic bodies from dying... 
Allergy and Immunology | Advanced Basic Science | Adhesion molecules | Cell activation | P2 receptors | Phagocytosis | Apoptosis | DENDRITIC CELLS | RECOGNITION | TUMOR-CELLS | IMMUNOLOGY | MICROGLIAL PHAGOCYTOSIS | NECROTIC CELLS | IMMUNE-SYSTEM | EPITHELIAL-CELLS | P2X RECEPTOR | VITRONECTIN RECEPTOR | EXPOSURE | Purinergic P2X Receptor Agonists - administration & dosage | Purinergic P2X Receptor Antagonists - pharmacology | Nucleotides - administration & dosage | Macrophages, Peritoneal - cytology | Integrin alphaVbeta3 - metabolism | Integrin alphaVbeta3 - genetics | Nucleotides - pharmacology | Receptors, Purinergic P2X - metabolism | Macrophage-1 Antigen - metabolism | Pyridoxal Phosphate - analogs & derivatives | Macrophages, Peritoneal - drug effects | Suramin - pharmacology | Endocytosis - immunology | Dextrans - metabolism | Purinergic P2Y Receptor Antagonists - pharmacology | Cell Line | Pyridoxal Phosphate - pharmacology | Purinergic P2Y Receptor Agonists - administration & dosage | Endocytosis - drug effects | Receptors, Purinergic P2Y - metabolism | Macrophages, Peritoneal - immunology | Cell Adhesion - drug effects | Sulfonic Acids - pharmacology | Purinergic P2X Receptor Agonists - pharmacology | Adenosine Diphosphate - pharmacology | Purinergic P2Y Receptor Agonists - pharmacology | Cell Adhesion - immunology | Cytophagocytosis - drug effects | Animals | Macrophage-1 Antigen - genetics | Cytophagocytosis - immunology | Mice | Receptors, Purinergic P2Y - immunology | Macrophages, Peritoneal - metabolism | Receptors, Purinergic P2X - immunology | Adenosine Diphosphate - analogs & derivatives | Index Medicus
Journal Article
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2016, Volume 163, pp. 122 - 131.e2
Purpose To compare the efficacies and safety profiles of 3% diquafosol and 0.1% sodium hyaluronate in patients with dry eye after cataract surgery. Design... 
Ophthalmology | OCULAR SURFACE | CORNEAL | WORKSHOP | POPULATION | HIGHER-ORDER ABERRATIONS | DISEASE | INS365 | OPHTHALMOLOGY | MODEL | SECRETION | HYALURONIC-ACID | Staining and Labeling - methods | Polyphosphates - adverse effects | Prospective Studies | Phacoemulsification - adverse effects | Humans | Middle Aged | Purinergic P2Y Receptor Agonists - adverse effects | Viscosupplements - adverse effects | Male | Polyphosphates - administration & dosage | Dry Eye Syndromes - diagnosis | Uracil Nucleotides - adverse effects | Viscosupplements - administration & dosage | Ophthalmic Solutions | Female | Surveys and Questionnaires | Uracil Nucleotides - administration & dosage | Fluorescent Dyes - administration & dosage | Hyaluronic Acid - adverse effects | Hyaluronic Acid - administration & dosage | Purinergic P2Y Receptor Agonists - administration & dosage | Dry Eye Syndromes - drug therapy | Tears - chemistry | Lissamine Green Dyes - administration & dosage | Visual Acuity | Fluorescein - administration & dosage | Aged | Tears - physiology | Lens Implantation, Intraocular | Administration, Topical | Dry Eye Syndromes - etiology | Eye | Medical colleges | Cataract | Care and treatment | Surgery | Ophthalmic drugs | Hyaluronic acid | Fluorescein | Cataracts | Sodium | Clinical trials | Eye diseases | Inflammation | FDA approval | Patient satisfaction | Eye surgery | Eye care products | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Cornea, ISSN 0277-3740, 08/2014, Volume 33, Issue 8, pp. 806 - 811
Journal Article
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 5/2016, Volume 41, Issue 4, pp. 549 - 555
Survivors after cardiac arrest (CA) due to AMI undergo PCI and then receive dual antiplatelet therapy. Mild therapeutic hypothermia (MTH) is recommended for... 
Myocardial infarction | Prasugrel | Medicine & Public Health | Hematology | Cardiac arrest | Clopidogrel | Cardiology | Ticagrelor |